Literature DB >> 2466071

Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment.

F Marongiu1, M Conti, G Mameli, M L Murtas, S Balzano, G Sorano, A M Mamusa, E Martino.   

Abstract

Plasma concentration of fibrinogen and B beta 15-42, a specific product of fibrinogen metabolism induced by plasmin, were measured in a group of patients with untreated hyperthyroidism and in controls. Significantly increased plasma levels of both parameters were observed in hyperthyroid patients. The restoration of euthyroidism either by antithyroid drug or by radioiodine caused a significant decrease of fibrinogen and B beta 15-42. These data indicate that hyperthyroidism is another clinical condition associated with increased concentration of fibrinogen and B beta 15-42.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466071     DOI: 10.1007/BF03350928

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

2.  Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid function.

Authors:  E Martino; G Bambini; L Bartalena; C Mammoli; F Aghini-Lombardi; L Baschieri; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1986-02       Impact factor: 3.478

3.  Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis.

Authors:  K Hymes; M Blum; H Lackner; S Karpatkin
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

4.  Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay.

Authors:  P B Romelli; F Pennisi; L Vancheri
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

5.  Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism.

Authors:  J R Edson; D R Fecher; R P Doe
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

6.  Measurement in human blood of fibrinogen/fibrin fragments containing the B beta 15-42 sequence.

Authors:  B Kudryk; D Robinson; C Netré; B Hessel; M Blombäck; B Blombäck
Journal:  Thromb Res       Date:  1982-02-01       Impact factor: 3.944

7.  Coagulation and fibrinolysis in thyroid disease.

Authors:  J A Rennie; P D Bewsher; L E Murchison; D Ogston
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

8.  Factor VIII activity and thyroid function.

Authors:  J S Rogers; S R Shane; F S Jencks
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

9.  Serum free thyroxine in patients with T3-toxicosis.

Authors:  E Martino; A Pacchiarotti; F Aghini-Lombardi; L Grasso; G Bambini; L Baschieri; A Pinchera
Journal:  Acta Endocrinol (Copenh)       Date:  1985-11
  9 in total
  11 in total

1.  Blood coagulation and fibrinolysis in patients with hyperthyroidism.

Authors:  C Erem; H O Ersoz; S S Karti; K Ukinç; A Hacihasanoglu; O Değer; M Telatar
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

2.  The effects of experimental hyperthyroidism on hemorheology and plasma fibrinogen concentration.

Authors:  S Ozdemir; R Yücel; N Dariyerli; S Toplan; M C Akyolcu; G Yigit; H Hatemi
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.633

Review 3.  Hemostasis and thyroid diseases revisited.

Authors:  M Franchini
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 4.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

5.  Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2008-09-12       Impact factor: 2.300

6.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 7.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

Review 8.  Coagulation and fibrinolysis in thyroid dysfunction.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

Review 9.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

Review 10.  Hemostasis in Overt and Subclinical Hyperthyroidism.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.